Fig. 1From: Multimodal image-guided surgery of HER2-positive breast cancer using [111In]In-DTPA-trastuzumab-IRDye800CW in an orthotopic breast tumor modelAbsorption (A) and fluorescence emission (E) of IRDye800CW and DTPA-trastuzumab-IRDye800CWBack to article page